SCHEMBL6535591

SCHEMBL6535591

COc1cc(C=CC(=O)O)ccc1OC(=O)[C@@H](N)Cc1c[nH]cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HPGD P15428 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ SNCA P37840 2/20 0.51
▸ PSMB5 P28074 1/20 0.50
▸ AKR1C3 P42330 1/20 0.49
▸ ACHE P22303 4/20 0.44
▸ CA2 P00918 5/20 0.44
▸ CA5A P35218 5/20 0.44
▸ CA9 Q16790 5/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA3 P07451 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ CSNK2A2 P19784 1/20 0.44
▸ CA4 P22748 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6535125 0.79 KDM4E (0.63) KDM4EALDH1A1HPGDALOX15MAPK1
Curcumin SCHEMBL28302521 0.78 APP (0.58) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL6535433 0.76 KDM4E (0.57) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL12538520 0.74 KDM4E (0.73) KDM4EALDH1A1HPGDALOX15MAPK1
Histidine SCHEMBL31147764 0.74 HDAC3 (0.46) KDM4EALDH1A1SMN1; SMN2PKM
SCHEMBL14851130 0.74 PSMB5 (0.67) KDM4EALDH1A1HPGDALOX15MAPK1
SCHEMBL8373479 0.74 TUBB1 (0.54) —
SCHEMBL8372887 0.74 TUBB1 (0.54) —
SCHEMBL8372885 0.74 TUBB1 (0.54) —
SCHEMBL10349516 0.72 KDM4E (0.73) KDM4EALDH1A1HPGDALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011702-A4 A METHOD FOR TREATING DIABETES, HYPERGLYCEMIA AND HYPOGLYCEMIA RICEX COMPANY (US) 2004-01-21 — — EP disclosed
US-6126943-A BY INGESTING A STABILIZED RICE BRAN DERIVATIVE. THE RICEX COMPANY (US) 2000-10-03 — — US disclosed
EP-1011702-A1 A METHOD FOR TREATING DIABETES, HYPERGLYCEMIA AND HYPOGLYCEMIA The Ricex Company (US) 2000-06-28 — — EP disclosed
WO-1999011144-A1 A METHOD FOR TREATING HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, AND ATHEROSCLEROSIS THE RICEX COMPANY, INC. (US) 1999-03-11 — — WO disclosed
WO-1999010002-A1 A METHOD FOR TREATING DIABETES, HYPERGLYCEMIA AND HYPOGLYCEMIA THE RICEX COMPANY, INC. (US) 1999-03-04 — — WO disclosed
Send feedback